1. Home
  2. ACGC vs EVMN Comparison

ACGC vs EVMN Comparison

Compare ACGC & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ACGC

ACP Holdings Acquisition Corp. Class A Ordinary Shares

N/A

Current Price

$10.06

Market Cap

292.6M

Sector

Finance

ML Signal

N/A

Logo Evommune Inc.

EVMN

Evommune Inc.

N/A

Current Price

$6.29

Market Cap

241.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ACGC
EVMN
Founded
2026
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
292.6M
241.3M
IPO Year
2026
2025

Fundamental Metrics

Financial Performance
Metric
ACGC
EVMN
Price
$10.06
$6.29
Analyst Decision
Buy
Analyst Count
0
11
Target Price
N/A
★ $24.13
AVG Volume (30 Days)
54.1K
★ 762.1K
Earning Date
N/A
11-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 75.23
EPS
★ N/A
N/A
Revenue
N/A
★ $13,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 85.71
52 Week Low
$9.92
$6.02
52 Week High
$10.12
$33.20

Technical Indicators

Market Signals
Indicator
ACGC
EVMN
Relative Strength Index (RSI) 60.49 19.52
Support Level $9.93 N/A
Resistance Level $10.12 $13.35
Average True Range (ATR) 0.01 0.53
MACD -0.00 -0.09
Stochastic Oscillator 25.00 5.72

Price Performance

Historical Comparison
ACGC
EVMN

About ACGC ACP Holdings Acquisition Corp. Class A Ordinary Shares

ACP Holdings Acquisition Corp is a blank check company.

About EVMN Evommune Inc.

Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.

Share on Social Networks: